| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 74,9 M € | -2.9% | 77,1 M € | +0.7% | 76,6 M € | -10.7% | 85,8 M € | +27.4% | 67,3 M € | +4.8% | 64,2 M € | +13.7% | 56,5 M € | -27.4% | 77,8 M € | +27.9% | 60,8 M € | -9.9% | 67,5 M € | +1.2% | 66,7 M € | +41.0% | 47,3 M € | +23.5% | 38,3 M € | -22.8% | 49,6 M € | +20.6% | 41,1 M € | +43.9% | 28,6 M € | -18.0% | 34,8 M € | +32.7% | 26,3 M € | |
| EBITDA | 320,2 k € | -85.7% | 2,2 M € | +403.9% | -736,1 k € | -153.5% | -290,3 k € | -121.4% | 1,4 M € | -9.2% | 1,5 M € | +447.8% | -429,3 k € | -146.3% | 927,3 k € | +322.6% | 219,4 k € | -82.9% | 1,3 M € | +3808.4% | 32,9 k € | -98.2% | 1,8 M € | +297.6% | -906,6 k € | -489.2% | 232,9 k € | -53.2% | 497,5 k € | +571.0% | -105,6 k € | -109.0% | 1,2 M € | +369.8% | -436,8 k € | |
| Operating profit | -97,8 k € | -105.8% | 1,7 M € | +236.8% | -1,2 M € | -645.9% | 227,5 k € | -80.1% | 1,1 M € | +63.0% | 700,4 k € | +512.6% | -169,8 k € | -195.9% | 177,1 k € | +350.6% | -70,7 k € | -160.6% | 116,5 k € | +197.2% | -119,8 k € | -107.7% | 1,5 M € | +220.3% | -1,3 M € | -5575.3% | 23,5 k € | -85.6% | 163,6 k € | +157.9% | -282,8 k € | -126.5% | 1,1 M € | +310.7% | -505,6 k € | |
| Profit/loss | 109,4 k € | -93.8% | 1,8 M € | +243.9% | -1,2 M € | -443.4% | -224,0 k € | -121.1% | 1,1 M € | +154.2% | 417,2 k € | +312.8% | -196,0 k € | -220.5% | 162,7 k € | +671.2% | -28,5 k € | -152.0% | 54,7 k € | +199.3% | -55,1 k € | -103.6% | 1,5 M € | +231.2% | -1,2 M € | -235.8% | -343,5 k € | -279.8% | 191,0 k € | +166.6% | -286,8 k € | -126.8% | 1,1 M € | +287.7% | -570,6 k € | |
| Equity | 15,2 M € | +6.3% | 14,3 M € | +13.9% | 12,6 M € | -8.8% | 13,8 M € | -1.6% | 14,0 M € | +3.2% | 13,6 M € | +3.2% | 13,2 M € | -1.5% | 13,4 M € | +1.2% | 13,2 M € | -0.2% | 13,2 M € | +0.4% | 13,2 M € | -0.4% | 13,2 M € | +12.9% | 11,7 M € | +40.0% | 8,4 M € | -3.9% | 8,7 M € | +2.2% | 8,5 M € | +214.6% | 2,7 M € | +65.4% | 1,6 M € | |
| Total assets | 32,5 M € | -1.1% | 32,9 M € | -1.6% | 33,4 M € | -17.6% | 40,6 M € | +18.6% | 34,2 M € | +7.8% | 31,7 M € | +7.4% | 29,5 M € | -14.8% | 34,6 M € | +35.6% | 25,5 M € | +7.3% | 23,8 M € | +1.1% | 23,5 M € | +13.3% | 20,8 M € | +17.3% | 17,7 M € | +8.5% | 16,3 M € | +11.0% | 14,7 M € | -0.5% | 14,8 M € | +2.3% | 14,5 M € | +28.7% | 11,2 M € | |
| Cash | 4,2 M € | -22.1% | 5,4 M € | +15.9% | 4,6 M € | -51.1% | 9,4 M € | +112.9% | 4,4 M € | -27.4% | 6,1 M € | +279.3% | 1,6 M € | -79.6% | 7,9 M € | +145.3% | 3,2 M € | -17.8% | 3,9 M € | +123.5% | 1,8 M € | -64.9% | 5,0 M € | +322.9% | 1,2 M € | -50.8% | 2,4 M € | -25.3% | 3,2 M € | +19.6% | 2,7 M € | +198.6% | 903,1 k € | -42.7% | 1,6 M € | |
| Debts | 17,1 M € | -7.8% | 18,5 M € | -9.7% | 20,5 M € | -23.3% | 26,7 M € | +32.7% | 20,1 M € | +11.2% | 18,1 M € | +10.9% | 16,3 M € | -23.1% | 21,2 M € | +75.5% | 12,1 M € | +14.5% | 10,6 M € | +2.2% | 10,3 M € | +37.6% | 7,5 M € | +30.4% | 5,8 M € | -23.8% | 7,6 M € | +28.3% | 5,9 M € | -5.0% | 6,2 M € | -46.9% | 11,7 M € | +22.3% | 9,6 M € | |
| Staff | 135 | 128,4 | 127,7 | 119,9 | 119,6 | 111,5 | 107,1 | 111,9 | 115,6 | 101,9 | 96,9 | 85,6 | 78,6 | 69,2 | 66,5 | 60,9 | 54,9 | 49,2 | ||||||||||||||||||
Non-profit organization · Bruxelles · incorporated on 17/08/1989 · 135,0 ETP
Non-profit organization profitable and well capitalised. Cash position declining (-22.1%).
Solid counterparty for a standard engagement.
MSF SUPPLY is a Non-profit organization incorporated in 1989. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Bruxelles. It employs on average 135,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette